Hydroxychloroquine Adherence Lowers Cardiovascular Risks A new study shows that adherence to the antimalarial agent si

Sep 16, 2023 4:00 pm
Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3_normal.jpg
Tweet Author
Dr. John Cush
Social Author Name
RheumNow
Tweet Content
Hydroxychloroquine Adherence Lowers Cardiovascular Risks A new study shows that adherence to the antimalarial agent significantly lowers future risk of cardiovascular events in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients. https://t.co/XzXcBP7XoO https://t.co/V2EQJ2GlpC
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2023 All Rights Reserved.

×